Interview With Gottlieb: A Discussion on Biosimilars, Opioids and Transparency

Interview With Gottlieb: A Discussion on Biosimilars, Opioids and Transparency

Source: 
RAPS.org
snippet: 

FDA Commissioner Scott Gottlieb spoke with Focus on Friday in a phone interview on the uptake of biosimilars in the US, generic drug labeling, the opioid crisis and FDA transparency. The interview was lightly edited for clarity.